ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Imperva, Inc.

Imperva, Inc. (IMPV)

55,74
0,00
(0,00%)
Geschlossen 13 Dezember 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
55,74
Gebot
45,00
Fragen
199.999,99
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
55,74
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

IMPV Neueste Nachrichten

Imperva Research Labs Reveals Abnormal Increase in DDoS Attack Length, Despite Popularity of Short Term Attacks

REDWOOD SHORES, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Imperva, Inc., the cybersecurity leader championing the fight to secure data and applications wherever they reside, published its May...

Imperva Recognized as a December 2018 Gartner Peer Insights Customers’ Choice for Web Application Firewalls

Imperva, Inc. (NASDAQ: IMPV), a leading global provider of best-in-class cybersecurity solutions on-premises, in the cloud, and across hybrid environments, today announced that it is a...

Imperva Announces Expiration of the Go-Shop Period

Imperva, Inc. (NASDAQ:IMPV), a cybersecurity leader that delivers best-in-class solutions to protect data and applications on-premises, in the cloud and across hybrid environments, today...

Imperva、Thoma Bravoによる買収に合意

買収取引完了後、 Imperva は株式非公開企業として、データとアプリケーションの安全をサイバー犯罪者から守る戦いに、今後も先頭に立って取組みを続けます。 (ビジネスワイヤ) -- オンプレミス、クラウ...

Imperva Announces Third Quarter 2018 Financial Results

Total revenue of $91.6 million, up 9% year-over-year Billings of $106.5 million, up 16% year-over-year GAAP operating income of $0.5 million; Non-GAAP operating income of $14.7...

WeissLaw LLP Investigates Imperva Inc. Acquisition

WeissLaw LLP Investigates Imperva Inc. Acquisition PR Newswire NEW YORK, Oct. 12, 2018 NEW YORK, Oct. 12, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Imperva, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Imperva, Inc. PR Newswire NEW YORK, Oct. 11, 2018 NEW YORK, Oct. 11, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating...

Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Imperva, Inc. has obtained a Fair Price in its Sale to Thoma Br...

Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Imperva, Inc. has obtained a Fair Price in its Sale to Thoma Bravo, LLC PR Newswire MILWAUKEE, Oct. 10, 2018 MILWAUKEE, Oct. 10...

Imperva (IMPV)Alert: Johnson Fistel Investigates Proposed Sale of Imperva, Inc.; Is $55.75 a Fair Price?

Imperva (IMPV)Alert: Johnson Fistel Investigates Proposed Sale of Imperva, Inc.; Is $55.75 a Fair Price? PR Newswire SAN DIEGO, Oct. 10, 2018 SAN DIEGO, Oct. 10, 2018 /PRNewswire/ -- Shareholder...

Imperva Announces Preliminary Third Quarter 2018 Financial Results

Imperva, Inc. (NASDAQ: IMPV), a leading global provider of best-in-class cybersecurity solutions on-premises, in the cloud, and across hybrid environments, today announced preliminary...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SHOTWSafety Shot Inc
US$ 0,25
(79,21%)
29,07k
PALIPalisade Bio Inc
US$ 2,36
(68,57%)
68,2M
LAESSEALSQ Corporation
US$ 1,8401
(60,01%)
256,79M
HIMXHimax Technologies Inc
US$ 9,73
(45,22%)
20,06M
TRVITrevi Therapeutics Inc
US$ 3,60
(44,58%)
63,85M
SPGCSacks Parente Golf Inc
US$ 0,3621
(-74,14%)
29,54M
KROSKeros Therapeutics Inc
US$ 18,40
(-73,20%)
14,41M
TFFPTFF Pharmaceuticals Inc
US$ 0,0657
(-59,62%)
13,24M
SFHGSamfine Creation Holdings Group Ltd
US$ 1,27
(-58,36%)
7,1M
APVOAptevo Therapeutics Inc
US$ 5,60
(-44,06%)
6,31M
GOEVCanoo Inc
US$ 0,1737
(33,62%)
970,8M
LAESSEALSQ Corporation
US$ 1,8401
(60,01%)
256,79M
NVDANVIDIA Corporation
US$ 137,34
(-1,41%)
159,23M
RGTIRigetti Computing Inc
US$ 5,9591
(-19,25%)
158,72M
CDTConduit Pharmaceuticals Inc
US$ 0,0798
(-9,63%)
119,28M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock